Duodenal jejunal bypass liner treatment for type 2 diabetes and obesity: comparison between 9 and 12 months implantation using data from a worldwide registry

被引：0
|
作者：
Ryder, R. E. J. [1 ]
Lopez-Gonzalez, R. [2 ]
Lazzara, C. [2 ]
Gebelli, J. P. [2 ]
Munro, L. [3 ]
Frydenberg, H. [3 ]
Stein, J. [4 ]
Battelino, T. [5 ]
Fishman, S. [6 ]
Byrne, J. [7 ]
de Jonge, C. [8 ]
Greve, J. -W. [9 ]
Cohen, R. [10 ]
Yadagiri, M. [1 ]
Sen Gupta, P. [1 ,11 ]
机构：
[1] Sandwell & West Birmingham NHS Trust Hosp, Diabet, Birmingham, W Midlands, England
[2] Bellvitge Univ Hosp, Gen & Digest Surg, Barcelona, Spain
[3] Epworth Med Fdn, Richmond, Australia
[4] DGD Klin Frankfurt Sachsenhausen, Frankfurt, Germany
[5] Univ Med Ctr Ljubljana, Endocrinol Diabet & Metab, Ljubljana, Slovenia
[6] Tel Aviv Sourasky Med Ctr, Gastroenterol, Tel Aviv, Israel
[7] Univ Hosp Southampton NHS Fdn Trust, Surg, Southampton, Hants, England
[8] Maastricht Univ, Surg, Med Ctr, Maastricht, Netherlands
[9] Maastricht Univ, Med Ctr, NUTRIM, Maastricht, Netherlands
[10] Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil
[11] Guys & St Thomas NHS Fdn Trust, Diabet & Endocrinol, London, England
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
792
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [21] Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes
    de Jonge, Charlotte
    Rensen, Sander S.
    D'Agnolo, Hedwig M. A.
    Bouvy, Nicole D.
    Buurman, Wim A.
    Greve, Jan Willem M.
    OBESITY SURGERY, 2014, 24 (02) : 337 - 341
  • [22] Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes
    Charlotte de Jonge
    Sander S. Rensen
    Hedwig M. A. D’Agnolo
    Nicole D. Bouvy
    Wim A. Buurman
    Jan Willem M. Greve
    Obesity Surgery, 2014, 24 : 337 - 341
  • [23] The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, a Multicenter Randomized Controlled Trial
    Koehestanie, Parviez
    de Jonge, Charlotte
    Berends, Frits J.
    Janssen, Ignace M.
    Bouvy, Nicole D.
    Greve, Jan Willem M.
    ANNALS OF SURGERY, 2014, 260 (06) : 984 - 992
  • [24] Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis
    Chen, Wenhui
    Feng, Jia
    Dong, Shiliang
    Guo, Jie
    Zhou, Fuqing
    Hu, Songhao
    Hu, Ruixiang
    Wang, Cunchuan
    Ma, Yi
    Dong, Zhiyong
    OBESITY REVIEWS, 2024, 25 (11)
  • [25] A MULTICENTER RANDOMIZED SHAM-CONTROLLED TRIAL OF A DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
    Thompson, Christopher C.
    Jirapinyo, Pichamol
    Brethauer, Stacy
    Shaheen, Nicholas J.
    Sullivan, Shelby A.
    Koch, Timothy R.
    Reavis, Kevin M.
    Abu Dayyeh, Barham K.
    Wilson, Erik B.
    Schulman, Allison R.
    Butsch, W. Scott
    Apovian, Caroline M.
    Schauer, Philip
    GASTROINTESTINAL ENDOSCOPY, 2022, 95 (06) : AB10 - AB11
  • [26] Safety- and efficacy-outcomes of the duodenal-jejunal bypass liner (DJBL) registry in obese patients with type 2 diabetes
    Sauer, N.
    Aberle, J.
    Lautenbach, A.
    Seufert, J.
    Laubner, K.
    DIABETOLOGIA, 2016, 59 : S39 - S40
  • [27] Gut Hormone Responses After Implantation of a Duodenal-Jejunal Bypass Liner and the Role in Remission of Type 2 Diabetes in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Berends, F.
    Janssen, I.
    Wahab, P.
    Groenen, M.
    Aarts, E.
    Mueller, M.
    de Wit, N.
    OBESITY SURGERY, 2013, 23 (08) : 1027 - 1027
  • [28] Neudesin, a Novel Regulator of Energy Metabolism in Obesity and Type 2 Diabetes Mellitus-The Effect of Acute Fasting and Endoscopic Duodenal-Jejunal Bypass Liner Implantation
    Kratochvilova, Helena
    Lacinova, Zdena
    Klouckova, Jana
    Kavalkova, Petra
    Cinkajzlova, Anna
    Trachta, Pavel
    Krizova, Jarmila
    Benes, Marek
    Vlasakova, Zuzana
    Pelikanova, Terezie
    Mraz, Milos
    Haluzik, Martin
    DIABETES, 2018, 67
  • [29] Effect of Endoscopic Duodenal-Jejunal Bypass Liner on Parameters of Insulin Sensitivity and Secretion in Subjects with Type 2 Diabetes Mellitus and Obesity
    Kudlackova, Michaela
    Mraz, Milos
    Haluzik, Martin
    Pelikanova, Terezie
    Benes, Marek
    Lapesova, Danuse
    Kobrova, Dana
    Vlasakova, Zuzana
    Brizova, Olga
    Lacinova, Zdenka
    DIABETES, 2019, 68
  • [30] DUODENAL-JEJUNAL BYPASS LINER FOR TREATMENT OF TYPE 2 DIABETES AND OBESITY: FOUR YEAR OUTCOMES IN THE FIRST NATIONAL HEALTH SERVICE (NHS) ENDOBARRIER SERVICE
    Ryder, R.
    Yadagiri, M.
    Burbridge, W.
    Irwin, S.
    Gandhi, H.
    Bashir, T.
    Allden, R.
    Wyres, M.
    Cull, M.
    Bleasdale, J.
    Fogden, E.
    Anderson, M.
    Sen Gupta, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A191 - A192
12345